Department of Pharmacology, Physiology and Toxicology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.
PPAR Res. 2011;2011:753917. doi: 10.1155/2011/753917. Epub 2011 Oct 26.
Atherogenic ω-6 lipids are physiological ligands of peroxisome proliferator-activated receptors (PPARs) and elicit pro- and antiatherogenic responses in vascular cells. The objective of this study was to investigate if ω-6 lipids modulated the early growth response-1 (Egr-1)/PPAR crosstalk thereby altering vascular function. Rat aortic smooth muscle cells (RASMCs) were exposed to ω-6 lipids, linoleic acid (LA), or its oxidized form, 13-HPODE (OxLA) in the presence or absence of a PPARα antagonist (MK886) or PPARγ antagonist (GW9662) or PPAR-specific siRNA. Our results demonstrate that ω-6 lipids, induced Egr-1 and monocyte chemotactic protein-1 (MCP-1) mRNA and protein levels at the acute phase (1-4 hrs) when PPARα was downregulated and at subacute phase (4-12 hrs) by modulating PPARγ, thus resulting in altered monocyte adhesion to RASMCs. We provide novel insights into the mechanism of action of ω-6 lipids on Egr-1/PPAR interactions in vascular cells and their potential in altering vascular function.
致动脉粥样硬化的 ω-6 脂质是过氧化物酶体增殖物激活受体 (PPARs) 的生理配体,在血管细胞中引发促动脉粥样硬化和抗动脉粥样硬化反应。本研究的目的是研究 ω-6 脂质是否调节早期生长反应因子-1 (Egr-1)/PPAR 相互作用,从而改变血管功能。在存在或不存在 PPARα 拮抗剂 (MK886) 或 PPARγ 拮抗剂 (GW9662) 或 PPAR 特异性 siRNA 的情况下,将 ω-6 脂质、亚油酸 (LA) 或其氧化形式 13-HPODE (OxLA) 暴露于大鼠主动脉平滑肌细胞 (RASMC) 中。我们的结果表明,ω-6 脂质在 PPARα 下调的急性期 (1-4 小时) 和亚急性期 (4-12 小时) 通过调节 PPARγ 诱导 Egr-1 和单核细胞趋化蛋白-1 (MCP-1) mRNA 和蛋白水平,从而导致单核细胞对 RASMC 的黏附发生改变。我们提供了关于 ω-6 脂质对血管细胞中 Egr-1/PPAR 相互作用的作用机制的新见解,以及它们改变血管功能的潜力。